Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RecruitingNot applicableNCT05868668
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.
Study details
- Official title
- Randomized Controlled Trial of Focused Shockwave, Radial Wave, and Sham Therapy for Erectile Dysfunction and Focused Shockwave and Sham Therapy for Chronic Pelvic Pain Syndrome in Patients With and Without History of Prostate Cancer
- Conditions
- Erectile Dysfunction Due to Arterial Insufficiency
- Erectile Dysfunction
- Erectile Dysfunction Due to Arterial Disease
- Chronic Pelvic Pain Syndrome
- Chronic Prostatitis
- Erectile Dysfunction Following Radical Prostatectomy
- Erectile Dysfunction Following Radiation Therapy
- Interventions
- Device: Focused shockwave
- Device: Radial wave
- Device: Sham treatment
- Sponsor
- The Cleveland Clinic
- Start date
- 2023-09-19
- Primary completion
- 2026-12
- Sex
- Male
- Age range
- from 40 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following) 1. Cis-gendered heterosexual adult males18 years old 2. Stable relationship of more than 3 months duration with currently willing sexual partner and desire for penetration. 3. Mild to moderate organic erectile dysfunction (IIEF-EF score 11-25) in the last 3 months 4. If ED responsive or partially responsive to current use of PDE5I, participant must be willing to discontinue PDE5I for 4 weeks prior to trial and remain off PDE5I for the duration of the study. Partially responsive ED is defined as inadequate response for desired sexual activity, or poorly maintained erection despite initially good response. 5. Agreeable to attempt sexual intercourse at least 4 times per month for duration of study without being under the influence of alcohol or recreational drugs 6. Morning total testosterone level over 300ng/dL Exclusion Criteria (ED): 1. Nerve-injury related ED (/spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting erectile functions (e.g, multiple sclerosis, alzheimer's disease, parkinsons disease, amyotrophic lateral sclerosis) 2. Untreated hypogonadism (morning total testosterone \<300 ng/dL) or on androgen deprivation therapy in the last 12 months 3. Predominately psychogenic ED based upon expert clinician opinion 4. Peyronie's disease, palpable plaque or curvature/penile anatomic abnormality that affects penetrative intercourse to any degree 5. History of non-superficial penile surgery (e.g, penile prosthesis, penectomy, plication, grafting) 6. History of penile injury or trauma (e.g, priapism, penile fracture) 7. Use of intracavernosal injection for ED within the last year 8. If diabetic, HbA1c 8% or higher within the past 12 months 9. Known corporal veno-occlusive dysfunction based on prior Doppler penile ultrasound 10. Current tobacco smoker, or has smoked in the past year 11. Poorly controlled hyperlipidemia 12. Poorly controlled hypertension 13. Severe cardiac disease or history of myocardial infarction 14. History of psychiatric disorder including bipolar disorder, current moderate or severe depression 15. Patients currently using SSRI or psychotropic medication 16. Severe ED based on IIEF-EF (score 10 or below) 17. Current acute prostatitis Chronic Pelvic Pain Syndrome Group: Inclusion Criteria (CPPS): (all of the following) 1. Adult males ≥18 years old 2. Chronic pelvic pain not explained by concurr…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05868668